Illumina India Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
- Paid Up Capital ₹ 4.99 Cr
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 316.12%
- Profit Growth 167.00%
- Ebitda 835.60%
- Net Worth 98.40%
- Total Assets 1383.53%
About Illumina India Biotechnology
Illumina India Biotechnology Private Limited (IIBPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 20 June 2018 (Six years and nine months 26 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 4.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Frederic Mahieu, Jeyandran Chandrasekaran, and Suresh Gadamsetti serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51100HR2018FTC074675
- Company No.
074675
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
20 Jun 2018
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Business Services
Illumina India Biotechnology Private Limited
Explore comprehensive data for Illumina India Biotechnology Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Illumina India Biotechnology?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Frederic Mahieu  | Additional Director | Current | |
Jeyandran Chandrasekaran  | Additional Director | 12-Apr-2024 | Current |
| Suresh Gadamsetti | Director | 06-May-2024 | Current |
Financial Performance of Illumina India Biotechnology.
Illumina India Biotechnology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 316.12% increase. The company also saw a substantial improvement in profitability, with a 167% increase in profit. The company's net worth Soared by an impressive increase of 98.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Illumina India Biotechnology?
In 2023, Illumina India Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Illumina India Biotechnology?
Illumina India Biotechnology has a workforce of 29 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Illumina India Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Illumina India Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Illumina India Biotechnology
Recent activity within the organization
- Director Appointment
Suresh Venkata Gadamsetti was appointed as a Director was appointed as a Director on 06 May 2024 & has been associated with this company since 11 months 9 days .
- Director Appointment
Jeyandran Chandrasekaran was appointed as a Additional Director was appointed as a Additional Director on 12 Apr 2024 & has been associated with this company since 1 year 2 days .
- Annual General Meeting
Illumina India Biotechnology Private Limited last Annual general meeting of members was held on 15 Sep 2023 as per latest MCA records.
- Balance Sheet
Illumina India Biotechnology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Company Incorporation
Illumina India Biotechnology Private Limited was registered on 20 Jun 2018 with Roc Delhi & aged 6 years 9 months as per MCA records.
Recent News, Updates & Announcement
- Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials.
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test.......
- MedGenome Launches KaryoSeq for Prenatal and Newborn Conditions, Bringing Illumina's Genome Sequencing to South Asia with NovaSeq X Plus.
When you're the first to bring Illumina's Genome Sequencing to South Asia and you're excited to launch KaryoSeq for prenatal and newborn conditions. NovaSeq X Plus is powerful and can do a lot of genomes quickly, making genomics more accessible. MedGenome is all about innovation and affordability, and KaryoSeq is another step in that direction..
Frequently asked questions
What is the Incorporation or founding date of Illumina India Biotechnology Private Limited?
Illumina India Biotechnology Private Limited was incorporated on 20 Jun 2018.
What is authorized share capital and paid-up capital of Illumina India Biotechnology Private Limited?
The authorized share capital of Illumina India Biotechnology Private Limited is ₹ 13.00 Cr and paid-up capital is ₹ 4.99 Cr.
Who are the current board members & directors of Illumina India Biotechnology Private Limited?
Currently 3 directors are associated with Illumina India Biotechnology Private Limited.
- Frederic Didier Mahieu
- Jeyandran Chandrasekaran
- Suresh Venkata Gadamsetti
What is the registered address of Illumina India Biotechnology Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Illumina India Biotechnology Private Limited is 2Nd Floor Plot No. 4, Minarch Tower Sector 44 -45 India, Sector -45, Haryana, 122003.
What is the corporate identification number (CIN) and company number of Illumina India Biotechnology Private Limited?
The corporate identification number (CIN) of Illumina India Biotechnology Private Limited is U51100HR2018FTC074675 and the company number is 074675 as per Ministry of Corporate Affairs (MCA).
What is the official website of Illumina India Biotechnology Private Limited?
The Official website of Illumina India Biotechnology Private Limited is https://www.illumina.com
What has been the recent revenue trend for Illumina India Biotechnology Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Illumina India Biotechnology Private Limited has risen by 316.12%.
How many employees does Illumina India Biotechnology Private Limited currently have?
As Per 2023 financial reports, 29 employees are currently employed by Illumina India Biotechnology Private Limited.
What change has been observed in the net worth of Illumina India Biotechnology Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Illumina India Biotechnology Private Limited has experienced an upsurge of 98.40%.
When was the last Balance Sheet of Illumina India Biotechnology Private Limited filed with the ROC?
The most recent Balance Sheet for Illumina India Biotechnology Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
VR
Vineet RustagiDirectorMK
Mannu KhandelwalDirectorTM
Tan MavisDirectorBY
Boon YimDirectorAG
Abhishek GuptaAdditional Director
Similar Companies Based on Business Support Services
Qwik Supply Chain Private Limited Thane, Maharashtra, India
Evonik India Private Limited Thane, Maharashtra, India
Philips India Limited 24 Parganas, West Bengal, India
Schneider Electric Private Limited Delhi, India
Nokia Solutions And Networks India Private Limited Delhi, India
Reliance Projects & Property Management Services Limited Ahmedabad, Gujarat, India
Ford Motor Private Limited Kanchipuram, Tamil Nadu, India